My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 149

    1.

    Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation.

    Kim SJ, Nian C, Doudet DJ, McIntosh CH.

    Diabetes. 2009 Mar;58(3):641-51. Epub 2008 Dec 10.PMID: 19073764 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice.

    Kim SJ, Nian C, Doudet DJ, McIntosh CH.

    Diabetes. 2008 May;57(5):1331-9. Epub 2008 Feb 25.PMID: 18299314 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.

    Drage M, Zaccone P, Phillips JM, Nicoletti F, Dawson J, Andrew Bradley J, Cooke A.

    Transplantation. 2002 Sep 15;74(5):611-9.PMID: 12352875 [PubMed - indexed for MEDLINE]Related articles

    4.

    Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.

    Guo Z, Wu T, Kirchhof N, Mital D, Williams JW, Azuma M, Sutherland DE, Hering BJ.

    Transplantation. 2001 Jun 15;71(11):1656-65.PMID: 11435979 [PubMed - indexed for MEDLINE]Related articles

    5.

    Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.

    Shi Q, Wang D, Hadley GA, Farber DL, Bartlett ST.

    Surgery. 2006 Aug;140(2):281-8.PMID: 16904981 [PubMed - indexed for MEDLINE]Related articles

    6.

    Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.

    Mu J, Woods J, Zhou YP, Roy RS, Li Z, Zycband E, Feng Y, Zhu L, Li C, Howard AD, Moller DE, Thornberry NA, Zhang BB.

    Diabetes. 2006 Jun;55(6):1695-704.PMID: 16731832 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.

    Gysemans C, Stoffels K, Giulietti A, Overbergh L, Waer M, Lannoo M, Feige U, Mathieu C.

    Diabetologia. 2003 Aug;46(8):1115-23. Epub 2003 Jul 17.PMID: 12879250 [PubMed - indexed for MEDLINE]Related articles

    8.

    Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.

    Pospisilik JA, Martin J, Doty T, Ehses JA, Pamir N, Lynn FC, Piteau S, Demuth HU, McIntosh CH, Pederson RA.

    Diabetes. 2003 Mar;52(3):741-50.PMID: 12606516 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.

    Rivereau AS, You S, Lalain S, Gouin E, Saï P.

    Transplantation. 1998 Sep 15;66(5):633-8.PMID: 9753345 [PubMed - indexed for MEDLINE]Related articles

    10.

    Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.

    Smith DK, Korbutt GS, Suarez-Pinzon WL, Kao D, Rajotte RV, Elliott JF.

    Transplantation. 1997 Oct 15;64(7):1040-9.PMID: 9381527 [PubMed - indexed for MEDLINE]Related articles

    11.

    Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.

    Demirci G, Strom TB, Li XC.

    J Immunol. 2003 Oct 1;171(7):3878-85.PMID: 14500690 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effect of STZ administration on islet isograft and allograft survival in NOD mice.

    Takayama Y, Ichikawa T, Maki T.

    Diabetes. 1993 Feb;42(2):324-9.PMID: 8425668 [PubMed - indexed for MEDLINE]Related articles

    13.

    Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice.

    Okitsu T, Bartlett ST, Hadley GA, Drachenberg CB, Farney AC.

    Am J Transplant. 2001 Jul;1(2):138-45.PMID: 12099361 [PubMed - indexed for MEDLINE]Related articles

    14.

    Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice.

    Suarez-Pinzon WL, Power RF, Rabinovitch A.

    Diabetologia. 2000 Sep;43(9):1149-56.PMID: 11043861 [PubMed - indexed for MEDLINE]Related articles

    15.

    Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice.

    Korbutt GS, Suarez-Pinzon WL, Power RF, Rajotte RV, Rabinovitch A.

    Diabetologia. 2000 Apr;43(4):474-80.PMID: 10819241 [PubMed - indexed for MEDLINE]Related articles

    16.

    Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.

    Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss H Jr, Ferran C, Sayegh MH.

    Transplantation. 2004 Apr 15;77(7):990-7.PMID: 15087759 [PubMed - indexed for MEDLINE]Related articles

    17.

    Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.

    Suarez-Pinzon W, Rajotte RV, Mosmann TR, Rabinovitch A.

    Diabetes. 1996 Oct;45(10):1350-7.PMID: 8826970 [PubMed - indexed for MEDLINE]Related articles

    18.

    TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.

    Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Rajotte RV, Power RF.

    J Immunol. 1997 Dec 15;159(12):6298-303.PMID: 9550435 [PubMed - indexed for MEDLINE]Related articles

    19.

    Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice.

    Mangada J, Pearson T, Brehm MA, Wicker LS, Peterson LB, Shultz LD, Serreze DV, Rossini AA, Greiner DL.

    Diabetes. 2009 Jan;58(1):165-73. Epub 2008 Nov 4.PMID: 18984741 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or transforming growth factor-beta in the islet grafts.

    Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Rajotte RV, Power RF.

    Transplantation. 1997 Dec 15;64(11):1525-31.PMID: 9415551 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity